Dave is a European Patent Attorney in our Biotechnology and Life Sciences Group. He is based in our Cambridge office and handles drafting, filing and prosecution of patent applications relating to therapeutic antibodies and peptides, diagnostic methods, recombinant enzymes, and vaccines.
Dave works with a variety of different clients including universities, small and medium-sized business as well as multinational pharmaceutical companies. He also has experience handling large patent families across many jurisdictions which has involved prosecuting applications at regional and national patent offices in Africa, South America and Eurasia. In addition, Dave has worked on Opposition proceedings at the European Patent Office. He has also prepared freedom-to-operate reports on behalf newly formed spin-out companies seeking investment.
Before joining the profession, Dave graduated from the University of Oxford in 2010 with a first class degree in molecular and cellular biochemistry and in 2014 was awarded a PhD from the University of Cambridge. While at Cambridge, Dave worked in the MRC Mitochondrial Biology Unit to investigate the structure and function of a multi-subunit oxidoreductase membrane protein using X-ray crystallography and cryo-electron microscopy. In the past, he has also worked for a global pharmaceutical company where he characterised models of neurodegenerative disease.
Dave joined J A Kemp in 2017 and qualified as a European Patent Attorney in 2018 having worked elsewhere in private practice since 2015.
University of Oxford, Master’s Degree in Biochemistry; University of Cambridge, PhD in Structural Biology
European Patent Attorney; Certificate in Intellectual Property Law, Queen Mary, University of London
Student Member of the Chartered Institute of Patent Attorneys (CIPA); Member of the Institute of Professional Representatives before the European Patent Office (EPI)